4//SEC Filing
Cline Christopher R. 4
Accession 0001415889-25-023209
CIK 0001438533other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 4:05 PM ET
Size
5.3 KB
Accession
0001415889-25-023209
Insider Transaction Report
Form 4
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2025-08-27$17.31/sh−470$8,136→ 92,656 total
Footnotes (1)
- [F1]This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of additional shares to cover the tax obligation that occurred upon the vesting of performance-based restricted stock units (PSUs) that vested in May 2025.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001943192
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 4:05 PM ET
- Size
- 5.3 KB